Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cumulus Neuroscience
Cumulus Neuroscience provides drug developers with at-home medical-grade tools to collect physiological and digital biomarkers that improve evaluation in neurodegeneration and psychiatry trials. The…
Cumulus Neuroscience
Cumulus Neuroscience provides drug developers with at-home medical-grade tools to collect physiological and digital biomarkers that improve evaluation in neurodegeneration and psychiatry trials. The…
TL;DR
Core offering: NeuLogiq platform combining at-home clinical-grade dry-sensor EEG, tablet cognitive tests, sleep measures, and analytics
Target customers: Pharmaceutical and clinical-trial teams running CNS studies
Funding highlights: Multiple institutional rounds and grants; notable rounds in May 2021 and July 2025
Regulatory status: 16-lead dry EEG headset reported as FDA 510(k) cleared and UKCA marked
Company Overview
Problem Domain
Clinical trial measurement challenges in neurodegeneration and psychiatry—need for objective, repeatable, scalable biomarkers and endpoints.
Founded
2015
Industry
Biotechnology
Tech Stack
Funding Track Record
£6.0 million
Financing announced to support development (company press release)
£3.25 million
Reported raise to expand commercial operations
Investor Signal
“Backed by life-science investors and public innovation agencies; early/lead strategic investor Dementia Discovery Fund; additional investors include LifeArc, ACF Investors, Clarendon Fund Managers, Co-FundNI, Innovate UK, UK Future Fund, and Whiterock Finance”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week